Brief: Eiger Biopharmaceuticals Inc CFO To Resign Effective Jan 20 2023
09/01/2023 22:09
Jan 9 (Reuters) - Eiger BioPharmaceuticals Inc EIGR.O :
* EIGER BIOPHARMACEUTICALS INC - ON JAN 3, SRIRAM RYALI
NOTIFIED
CO OF HIS RESIGNATION AS CO'S CHIEF FINANCIAL OFFICER, TO BE
EFFECTIVE JANUARY 20, 2023
Source: (shorturl.at/AFHL8)
Further company coverage: EIGR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview